Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4951 AL 4965

[A comparison of the efficacy and safety of memantal and original memantine in the treatment of mild and moderate dementia in Alzheimer's disease]

Shiryaev OY, Shapovalov DL, Polozova TM, Goncharova OV, Kuznetsova NA, Cherenkova EV, Fedorova EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):56-61. doi: 10.17116/jnevro201511510156-61.

Novel potential for the management of Alzheimer disease

Ginter E, Simko V, Weinrebova D, Ladecka Z.

Bratisl Lek Listy. 2015;116(10):580-1. doi: 10.4149/bll_2015_112.

Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial

Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR.

Neurology. 2015 Dec 1;85(22):1937-44. doi: 10.1212/WNL.0000000000002171. Epub 2015 Nov 4.

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease

Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.

Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.

The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients

Yang SY, Shan CL, Qing H, Wang W, Zhu Y, Yin MM, Machado S, Yuan TF, Wu T.

CNS Neurol Disord Drug Targets. 2015;14(10):1292-7. doi: 10.2174/1871527315666151111123319.

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

Portugal EM, Vasconcelos PG, Souza R, Lattari E, Monteiro-Junior RS, Machado S, Deslandes AC.

CNS Neurol Disord Drug Targets. 2015;14(9):1209-13. doi: 10.2174/1871527315666151111121749.

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy

Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.

Curr Drug Metab. 2015;16(8):719-27. doi: 10.2174/138920021608151107125757.

The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease

Ishikawa I, Shinno H, Ando N, Mori T, Nakamura Y.

Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61. Epub 2015 Nov 17.

Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study

Li P, Zhou YY, Lu D, Wang Y, Zhang HH.

Neurol Sci. 2016 May;37(5):797-803. doi: 10.1007/s10072-015-2405-9. Epub 2015 Nov 14.

Donepezil-associated manic episode with psychotic features: a case report and review of the literature

Hategan A, Bourgeois JA.

Gen Hosp Psychiatry. 2016 Jan-Feb;38:115.e1-4. doi: 10.1016/j.genhosppsych.2015.09.004. Epub 2015 Sep 25.

WAVEFORM WINDOW #30. A Case of Nocturnal Episodes

Ardeshna N.

Neurodiagn J. 2015 Sep;55(3):195-200. doi: 10.1080/21646821.2015.1074494.

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease

Goozee KG, Shah TM, Sohrabi HR, Rainey-Smith SR, Brown B, Verdile G, Martins RN.

Br J Nutr. 2016 Feb 14;115(3):449-65. doi: 10.1017/S0007114515004687. Epub 2015 Dec 14.

Low levels of aluminum can lead to behavioral and morphological changes associated with Alzheimer's disease and age-related neurodegeneration

Bondy SC.

Neurotoxicology. 2016 Jan;52:222-9. doi: 10.1016/j.neuro.2015.12.002. Epub 2015 Dec 12.

Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease

Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, Matsui T, Kozaki K, Fujii M, Ogawa T, Umegaki H, Urakami K, Nomura H, Kobayashi N, Nakanishi A, Washimi Y, Yonezawa H, Takahashi S, Kubota M, Wakutani Y, Ito D, Sasaki T, Matsubara E, Une K, Ishiki A, Yahagi Y, Shoji M, Sato H, Terayama Y, Kuzuya M, Araki N, Kodama M, Yamaguchi T, Arai H.

Geriatr Gerontol Int. 2017 Feb;17(2):211-218. doi: 10.1111/ggi.12696. Epub 2015 Dec 29.

Therapeutic strategies for Alzheimer's disease in clinical trials

Godyń J, Jończyk J, Panek D, Malawska B.

Pharmacol Rep. 2016 Feb;68(1):127-38. doi: 10.1016/j.pharep.2015.07.006. Epub 2015 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias